| 000 | 01457 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250515215052.0 | ||
| 264 | 0 | _c20100504 | |
| 008 | 201005s 0 0 eng d | ||
| 022 | _a1791-7530 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPatel, Bhaumik B | |
| 245 | 0 | 0 |
_aCurcumin targets FOLFOX-surviving colon cancer cells via inhibition of EGFRs and IGF-1R. _h[electronic resource] |
| 260 |
_bAnticancer research _cFeb 2010 |
||
| 300 |
_a319-25 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aColonic Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCurcumin _xadministration & dosage |
| 650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aOrganoplatinum Compounds _xadministration & dosage |
| 650 | 0 | 4 | _aOxaliplatin |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xpharmacology |
| 650 | 0 | 4 |
_aReceptor, IGF Type 1 _xantagonists & inhibitors |
| 700 | 1 | _aGupta, Deepshika | |
| 700 | 1 | _aElliott, Althea A | |
| 700 | 1 | _aSengupta, Vivek | |
| 700 | 1 | _aYu, Yingjie | |
| 700 | 1 | _aMajumdar, Adhip P N | |
| 773 | 0 |
_tAnticancer research _gvol. 30 _gno. 2 _gp. 319-25 |
|
| 999 |
_c19694058 _d19694058 |
||